 Francesca Cendali
Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucosephosphate Dehydrogenase | 5 | 2026 | 70 | 1.540 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 3 | 2025 | 34 | 1.300 |
Why?
| | Anemia, Sickle Cell | 7 | 2026 | 312 | 1.110 |
Why?
| | Exercise Tolerance | 1 | 2025 | 283 | 0.740 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 243 | 0.740 |
Why?
| | Erythrocytes | 8 | 2025 | 757 | 0.620 |
Why?
| | beta-Thalassemia | 3 | 2025 | 40 | 0.580 |
Why?
| | Metabolome | 4 | 2025 | 385 | 0.470 |
Why?
| | Hemolysis | 4 | 2025 | 243 | 0.460 |
Why?
| | Proteome | 4 | 2025 | 518 | 0.430 |
Why?
| | Hemopexin | 2 | 2025 | 38 | 0.430 |
Why?
| | Disease Models, Animal | 9 | 2026 | 4580 | 0.380 |
Why?
| | Metabolomics | 7 | 2025 | 727 | 0.330 |
Why?
| | Hypertension, Pulmonary | 4 | 2026 | 1980 | 0.330 |
Why?
| | Proteomics | 6 | 2025 | 1195 | 0.290 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2023 | 886 | 0.250 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2026 | 86 | 0.240 |
Why?
| | Oxidative Stress | 4 | 2025 | 1341 | 0.230 |
Why?
| | Iron | 2 | 2025 | 359 | 0.230 |
Why?
| | Maple Syrup Urine Disease | 1 | 2025 | 5 | 0.230 |
Why?
| | Haptoglobins | 1 | 2025 | 66 | 0.220 |
Why?
| | Cation Transport Proteins | 1 | 2026 | 118 | 0.220 |
Why?
| | Transcriptome | 2 | 2022 | 1046 | 0.220 |
Why?
| | Lung | 4 | 2025 | 4112 | 0.220 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.220 |
Why?
| | Blood Coagulation Disorders | 2 | 2023 | 189 | 0.210 |
Why?
| | Connective Tissue Diseases | 1 | 2025 | 84 | 0.210 |
Why?
| | Heme | 1 | 2025 | 89 | 0.210 |
Why?
| | Animals | 16 | 2026 | 38177 | 0.210 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2024 | 109 | 0.210 |
Why?
| | Bleomycin | 1 | 2025 | 253 | 0.210 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 14 | 0.200 |
Why?
| | Mice | 10 | 2026 | 18394 | 0.200 |
Why?
| | Balloon Occlusion | 1 | 2024 | 39 | 0.200 |
Why?
| | Sickle Cell Trait | 1 | 2023 | 15 | 0.190 |
Why?
| | Viral Nonstructural Proteins | 1 | 2023 | 67 | 0.190 |
Why?
| | Tranexamic Acid | 1 | 2023 | 53 | 0.190 |
Why?
| | Blood Preservation | 3 | 2022 | 354 | 0.190 |
Why?
| | Antifibrinolytic Agents | 1 | 2023 | 62 | 0.190 |
Why?
| | Spleen | 1 | 2025 | 508 | 0.190 |
Why?
| | Multiple Trauma | 1 | 2024 | 121 | 0.190 |
Why?
| | Amino Acid Transport System y+ | 1 | 2022 | 9 | 0.180 |
Why?
| | Sertoli Cells | 1 | 2022 | 28 | 0.180 |
Why?
| | Pulmonary Artery | 2 | 2025 | 1136 | 0.180 |
Why?
| | Ribosomes | 1 | 2023 | 191 | 0.180 |
Why?
| | Fibrinolysis | 1 | 2023 | 162 | 0.180 |
Why?
| | Rejuvenation | 1 | 2022 | 18 | 0.180 |
Why?
| | Polyamines | 1 | 2022 | 42 | 0.180 |
Why?
| | Cardiopulmonary Bypass | 1 | 2024 | 224 | 0.180 |
Why?
| | Athletic Performance | 1 | 2023 | 78 | 0.180 |
Why?
| | Pulmonary Fibrosis | 1 | 2025 | 395 | 0.170 |
Why?
| | Blood | 1 | 2022 | 109 | 0.170 |
Why?
| | Aurora Kinase B | 1 | 2021 | 11 | 0.170 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 66 | 0.170 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 31 | 0.170 |
Why?
| | DNA Methylation | 1 | 2026 | 686 | 0.160 |
Why?
| | Shock, Hemorrhagic | 1 | 2023 | 201 | 0.160 |
Why?
| | Interferons | 1 | 2022 | 188 | 0.160 |
Why?
| | Androgens | 1 | 2022 | 186 | 0.160 |
Why?
| | Aniline Compounds | 1 | 2021 | 119 | 0.160 |
Why?
| | Pyrazines | 1 | 2021 | 93 | 0.160 |
Why?
| | Immunotherapy, Adoptive | 1 | 2024 | 339 | 0.160 |
Why?
| | Protein Biosynthesis | 1 | 2023 | 458 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2021 | 83 | 0.160 |
Why?
| | Host-Pathogen Interactions | 1 | 2023 | 371 | 0.160 |
Why?
| | Databases, Genetic | 1 | 2021 | 249 | 0.160 |
Why?
| | Physical Exertion | 1 | 2021 | 207 | 0.150 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2192 | 0.150 |
Why?
| | Humans | 26 | 2026 | 145305 | 0.140 |
Why?
| | Hypoxia | 1 | 2026 | 1200 | 0.140 |
Why?
| | Hemorrhage | 1 | 2023 | 810 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 918 | 0.130 |
Why?
| | Liver Transplantation | 1 | 2025 | 827 | 0.130 |
Why?
| | Mitochondria | 1 | 2024 | 987 | 0.130 |
Why?
| | Swine | 3 | 2024 | 835 | 0.120 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 736 | 0.120 |
Why?
| | Oxygen | 1 | 2022 | 995 | 0.120 |
Why?
| | Liver | 1 | 2025 | 1893 | 0.120 |
Why?
| | Exercise | 3 | 2025 | 2206 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 3 | 2026 | 2541 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2021 | 1462 | 0.110 |
Why?
| | Male | 14 | 2026 | 72628 | 0.110 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 1800 | 0.110 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2021 | 684 | 0.100 |
Why?
| | Biomarkers, Tumor | 1 | 2021 | 1325 | 0.100 |
Why?
| | Pyrroles | 2 | 2026 | 218 | 0.100 |
Why?
| | Hemoglobin, Sickle | 2 | 2023 | 19 | 0.100 |
Why?
| | Anti-HIV Agents | 1 | 2020 | 890 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 4310 | 0.090 |
Why?
| | Rats | 3 | 2026 | 5616 | 0.090 |
Why?
| | Kynurenine | 2 | 2023 | 114 | 0.090 |
Why?
| | Blood Coagulation | 2 | 2024 | 271 | 0.090 |
Why?
| | Datasets as Topic | 2 | 2022 | 122 | 0.090 |
Why?
| | Indoles | 2 | 2026 | 501 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2023 | 2464 | 0.080 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 6007 | 0.070 |
Why?
| | Homeostasis | 2 | 2023 | 641 | 0.070 |
Why?
| | Amino Acids | 2 | 2023 | 522 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2024 | 3560 | 0.060 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2025 | 39 | 0.060 |
Why?
| | HIV Infections | 1 | 2020 | 3158 | 0.060 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 95 | 0.060 |
Why?
| | Heme Oxygenase-1 | 1 | 2025 | 74 | 0.050 |
Why?
| | Antimalarials | 1 | 2024 | 35 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2023 | 2833 | 0.050 |
Why?
| | Diethylhexyl Phthalate | 1 | 2024 | 15 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 107 | 0.050 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2024 | 150 | 0.050 |
Why?
| | Plastics | 1 | 2024 | 47 | 0.050 |
Why?
| | Ovalbumin | 1 | 2024 | 190 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2022 | 3613 | 0.050 |
Why?
| | Hydroxyurea | 1 | 2023 | 34 | 0.050 |
Why?
| | Aerosols | 1 | 2025 | 188 | 0.050 |
Why?
| | Phthalic Acids | 1 | 2024 | 52 | 0.050 |
Why?
| | Melanoma, Experimental | 1 | 2024 | 109 | 0.050 |
Why?
| | Succinates | 1 | 2023 | 24 | 0.050 |
Why?
| | Female | 7 | 2025 | 78605 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2026 | 612 | 0.050 |
Why?
| | Injections, Intramuscular | 1 | 2023 | 141 | 0.050 |
Why?
| | Lactates | 1 | 2023 | 83 | 0.050 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2023 | 118 | 0.050 |
Why?
| | Ventricular Function, Right | 1 | 2025 | 297 | 0.050 |
Why?
| | Glycolysis | 1 | 2025 | 340 | 0.050 |
Why?
| | Conserved Sequence | 1 | 2023 | 245 | 0.050 |
Why?
| | Vascular Remodeling | 1 | 2024 | 206 | 0.050 |
Why?
| | Random Allocation | 1 | 2023 | 363 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 164 | 0.050 |
Why?
| | Leydig Cells | 1 | 2022 | 15 | 0.050 |
Why?
| | Cystine | 1 | 2022 | 18 | 0.050 |
Why?
| | Bicycling | 1 | 2023 | 120 | 0.040 |
Why?
| | Glutamates | 1 | 2022 | 66 | 0.040 |
Why?
| | Thrombelastography | 1 | 2023 | 178 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 263 | 0.040 |
Why?
| | Spermatogenesis | 1 | 2022 | 91 | 0.040 |
Why?
| | Sulfur | 1 | 2022 | 64 | 0.040 |
Why?
| | Testis | 1 | 2022 | 163 | 0.040 |
Why?
| | Luteinizing Hormone | 1 | 2022 | 190 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2025 | 555 | 0.040 |
Why?
| | Cardiac Catheterization | 1 | 2025 | 561 | 0.040 |
Why?
| | Erythrocyte Count | 1 | 2021 | 21 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 48 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 55 | 0.040 |
Why?
| | Carnitine | 1 | 2021 | 90 | 0.040 |
Why?
| | Aorta | 1 | 2024 | 431 | 0.040 |
Why?
| | Erythrocyte Deformability | 1 | 2021 | 23 | 0.040 |
Why?
| | Purines | 1 | 2022 | 187 | 0.040 |
Why?
| | Cysteine | 1 | 2022 | 210 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 98 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 573 | 0.040 |
Why?
| | Monocytes | 1 | 2023 | 538 | 0.040 |
Why?
| | Fluorenes | 1 | 2020 | 46 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 117 | 0.040 |
Why?
| | Sofosbuvir | 1 | 2020 | 61 | 0.040 |
Why?
| | Glutathione | 1 | 2022 | 375 | 0.040 |
Why?
| | Protease Inhibitors | 1 | 2020 | 102 | 0.040 |
Why?
| | Exome | 1 | 2021 | 227 | 0.040 |
Why?
| | Tryptophan | 1 | 2021 | 182 | 0.040 |
Why?
| | Alanine | 1 | 2020 | 171 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2023 | 412 | 0.040 |
Why?
| | Blood Donors | 1 | 2021 | 143 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 920 | 0.040 |
Why?
| | Lactic Acid | 1 | 2021 | 302 | 0.040 |
Why?
| | Erythrocyte Transfusion | 1 | 2022 | 231 | 0.040 |
Why?
| | Benzimidazoles | 1 | 2020 | 190 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1894 | 0.040 |
Why?
| | Adult | 4 | 2025 | 40627 | 0.040 |
Why?
| | Lipids | 1 | 2023 | 712 | 0.040 |
Why?
| | Tenofovir | 1 | 2020 | 295 | 0.030 |
Why?
| | Acute Disease | 1 | 2021 | 1031 | 0.030 |
Why?
| | Fatty Acids | 1 | 2021 | 452 | 0.030 |
Why?
| | Kinetics | 1 | 2022 | 1630 | 0.030 |
Why?
| | Adenine | 1 | 2020 | 339 | 0.030 |
Why?
| | Testosterone | 1 | 2022 | 419 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 612 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2021 | 725 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 551 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2838 | 0.030 |
Why?
| | Middle Aged | 3 | 2025 | 36021 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2855 | 0.030 |
Why?
| | Macrophages | 1 | 2023 | 1514 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 589 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2021 | 974 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2022 | 3127 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1787 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2926 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2439 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6456 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5982 | 0.020 |
Why?
| | Infant | 1 | 2024 | 10101 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 8011 | 0.020 |
Why?
| | Child, Preschool | 1 | 2024 | 11863 | 0.020 |
Why?
| | Aged | 1 | 2025 | 26001 | 0.010 |
Why?
| | Adolescent | 1 | 2024 | 22507 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14163 | 0.010 |
Why?
| | Child | 1 | 2024 | 22712 | 0.010 |
Why?
|
|
Cendali's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|